We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Archer Aviation
ACHR
$4.78B
| $76K | ﹤0.01% |
16,448
-469
| -3% | -$1.72K |
|
2527
Inovio Pharmaceuticals
INO
$76.1M
| $76K | ﹤0.01% |
2,306
-66
| -3% | -$2.97K |
|
2528
Ultralife
ULBI
$116M
| $76K | ﹤0.01% |
14,104
-290,969
| -95% | -$1.56M |
|
2529
Information Services Group
III
$251M
| $75K | ﹤0.01% |
11,051
+721
| +7% | +$5.08K |
|
2530
Microvision
MVIS
$86.9M
| $75K | ﹤0.01% |
1,547
-1,140
| -42% | -$67.4K |
|
|
ASTR
2531
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $75K | ﹤0.01% |
1,559
-44
| -3% | -$2.91K |
|
2532
Viemed Healthcare
VMD
$355M
| $73K | ﹤0.01% |
14,685
-9,332
| -39% | -$43.3K |
|
2533
Geron
GERN
$949M
| $71K | ﹤0.01% |
50,128
+6,573
| +15% | +$7.33K |
|
2534
Centrus Energy
LEU
$3.78B
| $71K | ﹤0.01% |
2,096
+645
| +44% | +$27.1K |
|
2535
Wheels Up
UP
$191M
| $71K | ﹤0.01% |
116
+7
| +6% | +$5.05K |
|
2536
Atara Biotherapeutics
ATRA
$77.6M
| $70K | ﹤0.01% |
440
-13
| -3% | -$4.14K |
|
|
CODX
2537
Co-Diagnostics
CODX
$5.53M
| $70K | ﹤0.01% |
378
+53
| +16% | +$11K |
|
2538
Oramed Pharmaceuticals
ORMP
$175M
| $70K | ﹤0.01% |
13,704
+394
| +3% | +$4.04K |
|
2539
LifeVantage
LFVN
$84.3M
| $66K | ﹤0.01% |
13,868
+3,235
| +30% | +$18K |
|
2540
Oil-Dri
ODC
$1.28B
| $66K | ﹤0.01% |
4,628
-96
| -2% | -$1.5K |
|
2541
Offerpad Solutions
OPAD
$22.9M
| $66K | ﹤0.01% |
88
-2
| -2% | -$1.36K |
|
|
SGMO
2542
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $66K | ﹤0.01% |
15,897
-421
| -3% | -$2.5K |
|
|
FFAI
2543
Faraday Future Intelligent Electric
FFAI
$11.2M
| – | – |
0
| – | – |
|
|
ORC
2544
Orchid Island Capital
ORC
$1.3B
| $65K | ﹤0.01% |
4,656
-236
| -5% | -$4.45K |
|
2545
SmartRent
SMRT
$261M
| $65K | ﹤0.01% |
13,436
-383
| -3% | -$2.76K |
|
|
CTIC
2546
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $65K | ﹤0.01% |
12,719
-363
| -3% | -$1.08K |
|
|
AGEN
2547
Agenus
AGEN
$291M
| $63K | ﹤0.01% |
1,740
+46
| +3% | +$2.49K |
|
2548
LSI Industries
LYTS
$909M
| $63K | ﹤0.01% |
10,567
-981
| -8% | -$6.52K |
|
|
BBIG
2549
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $63K | ﹤0.01% |
1,867
+489
| +35% | +$19.5K |
|
2550
AvePoint
AVPT
$2.75B
| $62K | ﹤0.01% |
12,574
-358
| -3% | -$2.05K |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.